secwatch.observer — SEC 8-K summary
======================================

Issuer:     Shockwave Medical, Inc. (—)
CIK:        0001642545
Form:       8-K
Filed at:   2024-05-06T23:59:59+00:00
Accession:  0001171843-24-002571
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Shockwave Medical Q1 revenue up 36% to $218.8M, net income $55.3M; withdraws 2024 guidance due to JNJ acquisition
--------------------------------------------------------------------------------

- Revenue $218.8M (+36% YoY); net income $55.3M ($1.44 diluted EPS) vs $39.1M ($1.01) in Q1 2023.
- Gross margin 87%; operating expenses $148.2M (+48% YoY) on sales force expansion.
- Adjusted EBITDA $68.5M, up 19% from $57.5M in Q1 2023.
- Withdraws full-year 2024 guidance due to proposed Johnson & Johnson acquisition.
- Cash, cash equivalents and short-term investments $1,029.2M as of March 31, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1642545/000117184324002571/0001171843-24-002571-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1642545/000117184324002571/f8k_050624.htm
  HTML page:      https://secwatch.observer/filing/0001171843-24-002571

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer